These data further demonstrated that cetuximab downregulated tumor-induced angiogenesis in the 2cKO mouse model of HNSCC by inhibiting the HIF-1α and Notch1 pathways. The gene discussed is NOTCH1; the disease is head and neck squamous cell carcinoma.